Scancell is developing novel therapeutic vaccines for the treatment of cancer and infectious diseases. Scancellís first cancer vaccine SCIB1 is being developed for the treatment of melanoma and is in Phase I clinical trials.
|Annual Report 2011 in PDF *||30/04/2011||30/06/2011|
|Annual Report 2010 in PDF||30/04/2010||13/07/2010|
|Annual Report 2009 in PDF||30/04/2009|
|Interim Results 2010 in PDF *||31/10/2010||31/01/2011|
|Interim Results 2009 in PDF||31/10/2009||29/01/2010|